FIC20200039I1 - Kefiderokoli valinnaisesti farmaseuttisesti hyväksyttävän suolan tai solvaatin muodossa - Google Patents
Kefiderokoli valinnaisesti farmaseuttisesti hyväksyttävän suolan tai solvaatin muodossaInfo
- Publication number
- FIC20200039I1 FIC20200039I1 FIC20200039C FIC20200039C FIC20200039I1 FI C20200039 I1 FIC20200039 I1 FI C20200039I1 FI C20200039 C FIC20200039 C FI C20200039C FI C20200039 C FIC20200039 C FI C20200039C FI C20200039 I1 FIC20200039 I1 FI C20200039I1
- Authority
- FI
- Finland
- Prior art keywords
- cefiderocol
- solvate
- optionally
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D505/10—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D505/12—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 substituted in position 7
- C07D505/14—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 substituted in position 7 with hetero atoms directly attached in position 7
- C07D505/16—Nitrogen atoms
- C07D505/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D505/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D505/24—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by doubly-bound nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/06—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 containing at least one condensed beta-lactam ring system, provided for by groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00, e.g. a penem or a cepham system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008280828 | 2008-10-31 | ||
| EP09823578.1A EP2341053B1 (en) | 2008-10-31 | 2009-10-27 | Cephalosporin having catechol group |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FIC20200039I1 true FIC20200039I1 (fi) | 2020-10-19 |
Family
ID=42128829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIC20200039C FIC20200039I1 (fi) | 2008-10-31 | 2020-10-19 | Kefiderokoli valinnaisesti farmaseuttisesti hyväksyttävän suolan tai solvaatin muodossa |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US9238657B2 (fi) |
| EP (2) | EP2341053B1 (fi) |
| JP (2) | JP5498393B2 (fi) |
| KR (1) | KR101655961B1 (fi) |
| CN (1) | CN102203100B (fi) |
| AU (1) | AU2009310959B2 (fi) |
| BR (1) | BRPI0921701B8 (fi) |
| CA (1) | CA2736953C (fi) |
| CL (1) | CL2011000939A1 (fi) |
| CO (1) | CO6331443A2 (fi) |
| CR (1) | CR20110144A (fi) |
| CY (2) | CY1118536T1 (fi) |
| DK (1) | DK2960244T3 (fi) |
| EA (1) | EA019520B1 (fi) |
| ES (2) | ES2602969T3 (fi) |
| FI (1) | FIC20200039I1 (fi) |
| FR (1) | FR20C1050I2 (fi) |
| HR (1) | HRP20161408T1 (fi) |
| HU (2) | HUE031802T2 (fi) |
| IL (1) | IL211720A (fi) |
| LT (2) | LT2960244T (fi) |
| MA (1) | MA32731B1 (fi) |
| ME (1) | ME02666B (fi) |
| MX (1) | MX2011004636A (fi) |
| MY (1) | MY155655A (fi) |
| NL (1) | NL301067I2 (fi) |
| NO (1) | NO2020035I1 (fi) |
| NZ (1) | NZ591728A (fi) |
| PE (1) | PE20120010A1 (fi) |
| PL (1) | PL2960244T3 (fi) |
| PT (1) | PT2960244T (fi) |
| RS (1) | RS55365B1 (fi) |
| SI (1) | SI2960244T1 (fi) |
| SM (1) | SMT201600397B (fi) |
| TW (1) | TWI535727B (fi) |
| UA (1) | UA105190C2 (fi) |
| WO (1) | WO2010050468A1 (fi) |
| ZA (1) | ZA201102024B (fi) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8883772B2 (en) | 2007-10-09 | 2014-11-11 | Sopharmia, Inc. | Broad spectrum beta-lactamase inhibitors |
| MX2011004636A (es) | 2008-10-31 | 2011-06-20 | Shionogi & Co | Cefarosporinas que tienen un grupo catecol. |
| JP5909441B2 (ja) | 2010-04-05 | 2016-04-26 | 塩野義製薬株式会社 | カテコール基を有するセフェム化合物 |
| US8883773B2 (en) | 2010-04-05 | 2014-11-11 | Shionogi & Co., Ltd. | Cephem compound having pseudo-catechol group |
| JP5852562B2 (ja) * | 2010-04-28 | 2016-02-03 | 塩野義製薬株式会社 | 新規なセフェム誘導体 |
| EP2966061B1 (en) * | 2011-03-04 | 2017-05-03 | Life Technologies Corporation | Compounds and methods for conjugation of biomolecules |
| KR101719556B1 (ko) * | 2011-03-30 | 2017-03-24 | 주식회사 레고켐 바이오사이언스 | 신규한 세파로스포린 유도체 및 이를 함유하는 의약 조성물 |
| CN103635478A (zh) * | 2011-04-28 | 2014-03-12 | 盐野义制药株式会社 | 具有儿茶酚或假儿茶酚结构的新颖头孢烯类化合物 |
| US9242999B2 (en) | 2011-06-27 | 2016-01-26 | Shionogi & Co., Ltd. | Cephem compound having pyridinium group |
| TWI547496B (zh) | 2011-10-04 | 2016-09-01 | 葛蘭素集團公司 | 抗菌化合物 |
| US9290515B2 (en) | 2011-10-04 | 2016-03-22 | Shionogi & Co., Ltd | Cephem derivative having catechol group |
| KR20150076223A (ko) | 2012-10-29 | 2015-07-06 | 시오노기세야쿠 가부시키가이샤 | 2-알킬 세펨 화합물을 위한 중간체의 제조 방법 |
| UY35103A (es) * | 2012-10-29 | 2014-05-30 | Glaxo Group Ltd | Compuestos de cefem 2-sustituidos |
| WO2014104148A1 (ja) * | 2012-12-26 | 2014-07-03 | 塩野義製薬株式会社 | セフェム化合物 |
| WO2015035376A2 (en) | 2013-09-09 | 2015-03-12 | Calixa Therapeutics, Inc. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
| LT3122745T (lt) | 2014-03-24 | 2019-04-10 | Novartis Ag | Monobaktamo organiniai junginiai, skirti bakterinių infekcijų gydymui |
| JP6377570B2 (ja) * | 2014-04-28 | 2018-08-22 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ | ２−置換セフェム化合物を含有する医薬組成物 |
| RU2686740C2 (ru) | 2014-06-11 | 2019-04-30 | Венаторкс Фармасьютикалс, Инк. | Ингибиторы бета-лактамазы |
| HRP20211524T1 (hr) * | 2014-09-04 | 2021-12-24 | Shionogi & Co., Ltd. | Sol derivata cefalosporina, kristalni kruti oblik istog i postupak za njegovu proizvodnju |
| WO2016035847A1 (ja) * | 2014-09-04 | 2016-03-10 | 塩野義製薬株式会社 | セファロスポリン誘導体の中間体およびその製造方法 |
| US9949982B2 (en) | 2014-09-04 | 2018-04-24 | Shionogi & Co., Ltd. | Preparation containing cephalosporin having a catechol moiety |
| US10464896B2 (en) | 2015-06-11 | 2019-11-05 | Basilea Pharmaceutica International AG | Efflux-pump inhibitors and therapeutic uses thereof |
| WO2017050218A1 (en) | 2015-09-23 | 2017-03-30 | Novartis Ag | Salts and solid forms of monobactam antibiotic |
| BR112018009725A8 (pt) | 2015-12-10 | 2019-02-26 | Naeja Rgm Pharmaceuticals Ulc | compostos de cefém, sua produção e uso |
| US10858366B2 (en) | 2016-03-08 | 2020-12-08 | Novartis Ag | Tricyclic compounds useful to treat orthomyxovirus infections |
| BR112018074985A2 (pt) * | 2016-06-17 | 2019-03-12 | Wockhardt Limited | composições antibacterianas |
| JOP20170169A1 (ar) | 2016-08-29 | 2019-01-30 | Novartis Ag | مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو |
| EP3630783A4 (en) | 2017-05-26 | 2021-03-03 | Venatorx Pharmaceuticals, Inc. | PENICILLIN BINDING PROTEIN INHIBITORS |
| KR20200038922A (ko) * | 2017-06-09 | 2020-04-14 | 포브 신서시스 인코포레이티드 | 세균 감염의 치료를 위한 카바페넴 화합물 및 조성물 |
| US11414411B2 (en) | 2017-08-02 | 2022-08-16 | Novartis Ag | Chemical process for manufacturing monobactam antibiotic and intermediates thereof |
| KR20230031990A (ko) | 2018-02-28 | 2023-03-07 | 노파르티스 아게 | 인플루엔자의 치료를 위한 오르토믹소바이러스 복제의 억제제로서의 10-(디(페닐)메틸)-4-히드록시-8,9,9a,10-테트라히드로-7h-피롤로[1',2':4,5]피라지노[1,2-b]피리다진-3,5-디온 유도체 및 관련 화합물 |
| WO2020184399A1 (ja) * | 2019-03-08 | 2020-09-17 | 塩野義製薬株式会社 | 抗菌用医薬組成物 |
| WO2021043973A1 (en) | 2019-09-06 | 2021-03-11 | Nabriva Therapeutics GmbH | Siderophore cephalosporin conjugates and uses thereof |
| US20230121689A1 (en) | 2020-01-22 | 2023-04-20 | Shanghai Senhui Medicine Co., Ltd. | Cephalosporin antibacterial compound and pharmaceutical application thereof |
| TW202220663A (zh) | 2020-07-28 | 2022-06-01 | 日商鹽野義製藥股份有限公司 | 含有具有鄰苯二酚基之頭孢菌素類的凍結乾燥製劑及其製造方法 |
| US20240132518A1 (en) | 2021-01-12 | 2024-04-25 | Shanghai Senhui Medicine Co., Ltd. | Cephalosporin antibacterial compound and preparation method therefor |
| CN113698365A (zh) * | 2021-08-30 | 2021-11-26 | 成都大学 | 一种头孢地尔侧链的制备方法 |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL47168A (en) | 1974-05-09 | 1979-07-25 | Toyama Chemical Co Ltd | Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same |
| JPS57118588A (en) | 1981-11-26 | 1982-07-23 | Toyama Chem Co Ltd | Novel cephalosporin |
| DE3207840A1 (de) | 1982-03-04 | 1983-09-15 | Hoechst Ag, 6230 Frankfurt | "cephalosporinderivate und verfahren zu ihrer herstellung" |
| GR79784B (fi) | 1983-01-21 | 1984-10-31 | Beecham Group Plc | |
| NO165842C (no) | 1984-04-23 | 1991-04-17 | Takeda Chemical Industries Ltd | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser. |
| EP0168177A3 (en) | 1984-06-28 | 1987-04-01 | Pfizer Limited | Cephalosporin antibiotics |
| EP0203271B1 (en) | 1985-03-01 | 1993-05-26 | Takeda Chemical Industries, Ltd. | Antibacterial compounds, their production and use |
| JPH068300B2 (ja) * | 1985-08-02 | 1994-02-02 | 萬有製薬株式会社 | 新規セフアロスポリン誘導体 |
| EP0211656A3 (en) | 1985-08-10 | 1988-03-09 | Beecham Group Plc | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them |
| JPH07107069B2 (ja) * | 1985-09-03 | 1995-11-15 | 大塚化学株式会社 | セフアロスポリン化合物の新規誘導体、その製造法及び該誘導体を含有する医薬組成物 |
| ATE82976T1 (de) * | 1985-09-03 | 1992-12-15 | Otsuka Kagaku Kk | Cephalosporinderivate. |
| JPS62158291A (ja) * | 1986-01-07 | 1987-07-14 | Sagami Chem Res Center | セフアロスポリン誘導体 |
| DE3750411T2 (de) | 1986-04-14 | 1995-03-16 | Banyu Pharma Co Ltd | Cephalosporinderivate, Verfahren zu ihrer Herstellung und antibakterielle Präparate. |
| ATE92927T1 (de) * | 1986-04-14 | 1993-08-15 | Banyu Pharma Co Ltd | 1-carboxy-1-vinyloxyiminoaminothiazolcephalosporin-derivate und deren herstellung. |
| IE61679B1 (en) * | 1987-08-10 | 1994-11-16 | Fujisawa Pharmaceutical Co | Water-soluble antibiotic composition and water-soluble salts of new cephem compounds |
| GB8719875D0 (en) | 1987-08-22 | 1987-09-30 | Beecham Group Plc | Compounds |
| JPH0228185A (ja) * | 1988-04-14 | 1990-01-30 | Tanabe Seiyaku Co Ltd | セファロスポリン化合物及びその合成中間体 |
| GB8811055D0 (en) | 1988-05-10 | 1988-06-15 | Ici Plc | Antibiotic compounds |
| US5149803A (en) * | 1988-05-10 | 1992-09-22 | Imperial Chemical Industries Plc | Intermediates for cephalosporin compounds |
| PH25965A (en) | 1988-06-06 | 1992-01-13 | Fujisawa Pharmaceutical Co | New cephem compounds which have antimicrobial activities |
| US5244890A (en) * | 1988-06-06 | 1993-09-14 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| GB8813945D0 (en) | 1988-06-13 | 1988-07-20 | Fujisawa Pharmaceutical Co | New cephem compounds & process for preparation thereof |
| GB8817653D0 (en) * | 1988-07-25 | 1988-09-01 | Fujisawa Pharmaceutical Co | New cephem compounds & processes for preparation thereof |
| JPH02275886A (ja) | 1988-12-29 | 1990-11-09 | Tanabe Seiyaku Co Ltd | セファロスポリン化合物及びその製法 |
| CA2005787A1 (en) | 1988-12-29 | 1990-06-29 | Masao Wada | Cephalosporin compounds |
| US5143910A (en) * | 1989-09-07 | 1992-09-01 | Shionogi & Co., Ltd. | Piperaziniocephalosporins |
| GB9005246D0 (en) | 1990-03-08 | 1990-05-02 | Fujisawa Pharmaceutical Co | New cephem compounds and processes for preparation thereof |
| US5126336A (en) * | 1990-08-23 | 1992-06-30 | Bristol-Myers Squibb Company | Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof |
| US5095012A (en) | 1990-08-23 | 1992-03-10 | Bristol-Myers Squibb Company | Antibiotic c-7 catechol-substituted cephalosporin compounds, compositions, and method of use thereof |
| US5234920A (en) | 1990-08-23 | 1993-08-10 | Bristol-Myers Squibb Company | Antibiotic C-7 catechol-substituted cephalosporin compounds, compositions, and method of use thereof |
| US5194433A (en) * | 1990-11-13 | 1993-03-16 | Bristol-Myers Squibb Company | Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof |
| GB9111406D0 (en) | 1991-05-28 | 1991-07-17 | Fujisawa Pharmaceutical Co | New cephem compounds and processes for preparation thereof |
| GB9118672D0 (en) | 1991-08-30 | 1991-10-16 | Fujisawa Pharmaceutical Co | New cephem compounds and processes for preparation thereof |
| EP0628562A1 (fr) | 1993-06-10 | 1994-12-14 | Roussel Uclaf | Céphalosporines comportant en position 7 un radical oxymino substitué, leurs intermédiaires, leurs procédé de préparation et leur application comme médicaments |
| WO1999033839A1 (en) | 1997-12-26 | 1999-07-08 | Cheil Jedang Corporation | Cephem derivatives and a method for producing the compounds and an antibacterial composition containing the compounds |
| NZ527276A (en) | 2001-03-27 | 2004-11-26 | Actelion Pharmaceuticals Ltd | 1,2,3,4-tetrahydroisoquinoline derivatives as urotensin II receptor antagonists |
| JP2003078440A (ja) | 2001-08-30 | 2003-03-14 | Kyocera Corp | 高周波スイッチ回路 |
| TW200305422A (en) * | 2002-03-18 | 2003-11-01 | Shionogi & Co | Broad spectrum cefem compounds |
| US6713625B2 (en) | 2002-05-23 | 2004-03-30 | Orchid Chemicals & Pharmaceuticals Ltd. | Process for the preparation of cefditoren using the thioester of thiazolylacetic acid |
| JP4892926B2 (ja) | 2005-10-25 | 2012-03-07 | 宇部興産株式会社 | スルホン化芳香族ブロック共重合体の製造方法 |
| TW200637559A (en) | 2005-03-29 | 2006-11-01 | Shionogi & Co | 3-propenylcefem derivative |
| JP4557859B2 (ja) | 2005-09-29 | 2010-10-06 | 富士通株式会社 | 周波数分割多重送受信装置及び送受信方法 |
| WO2007096740A2 (en) | 2006-02-20 | 2007-08-30 | Orchid Research Laboratories Limited | Novel cephalosporins |
| US20090012054A1 (en) * | 2006-03-16 | 2009-01-08 | Astellas Pharma Inc. | Cephem Compounds and Use as Antimicrobial Agents |
| MX2011004636A (es) | 2008-10-31 | 2011-06-20 | Shionogi & Co | Cefarosporinas que tienen un grupo catecol. |
| JP5909441B2 (ja) * | 2010-04-05 | 2016-04-26 | 塩野義製薬株式会社 | カテコール基を有するセフェム化合物 |
| US8883773B2 (en) * | 2010-04-05 | 2014-11-11 | Shionogi & Co., Ltd. | Cephem compound having pseudo-catechol group |
| JP5852562B2 (ja) * | 2010-04-28 | 2016-02-03 | 塩野義製薬株式会社 | 新規なセフェム誘導体 |
-
2009
- 2009-10-27 MX MX2011004636A patent/MX2011004636A/es active IP Right Grant
- 2009-10-27 US US13/063,878 patent/US9238657B2/en active Active
- 2009-10-27 DK DK15175084.1T patent/DK2960244T3/en active
- 2009-10-27 CA CA2736953A patent/CA2736953C/en active Active
- 2009-10-27 NZ NZ591728A patent/NZ591728A/xx unknown
- 2009-10-27 UA UAA201106802A patent/UA105190C2/ru unknown
- 2009-10-27 MY MYPI2011001201A patent/MY155655A/en unknown
- 2009-10-27 JP JP2010535799A patent/JP5498393B2/ja active Active
- 2009-10-27 WO PCT/JP2009/068400 patent/WO2010050468A1/ja active Application Filing
- 2009-10-27 LT LTEP15175084.1T patent/LT2960244T/lt unknown
- 2009-10-27 PT PT151750841T patent/PT2960244T/pt unknown
- 2009-10-27 KR KR1020117012300A patent/KR101655961B1/ko active IP Right Grant
- 2009-10-27 BR BRPI0921701A patent/BRPI0921701B8/pt active IP Right Grant
- 2009-10-27 HU HUE15175084A patent/HUE031802T2/en unknown
- 2009-10-27 CN CN200980143827.5A patent/CN102203100B/zh active Active
- 2009-10-27 PL PL15175084T patent/PL2960244T3/pl unknown
- 2009-10-27 EP EP09823578.1A patent/EP2341053B1/en active Active
- 2009-10-27 SI SI200931549A patent/SI2960244T1/sl unknown
- 2009-10-27 EP EP15175084.1A patent/EP2960244B1/en active Active
- 2009-10-27 ME MEP-2016-246A patent/ME02666B/me unknown
- 2009-10-27 ES ES15175084.1T patent/ES2602969T3/es active Active
- 2009-10-27 AU AU2009310959A patent/AU2009310959B2/en active Active
- 2009-10-27 RS RS20160919A patent/RS55365B1/sr unknown
- 2009-10-27 EA EA201170632A patent/EA019520B1/ru unknown
- 2009-10-27 ES ES09823578.1T patent/ES2564836T3/es active Active
- 2009-10-27 PE PE2011000941A patent/PE20120010A1/es active IP Right Grant
- 2009-10-30 TW TW098136792A patent/TWI535727B/zh active
-
2011
- 2011-03-14 IL IL211720A patent/IL211720A/en active IP Right Grant
- 2011-03-17 ZA ZA2011/02024A patent/ZA201102024B/en unknown
- 2011-03-18 CR CR20110144A patent/CR20110144A/es unknown
- 2011-04-27 CL CL2011000939A patent/CL2011000939A1/es unknown
- 2011-04-29 MA MA33798A patent/MA32731B1/fr unknown
- 2011-05-02 CO CO11053320A patent/CO6331443A2/es active IP Right Grant
-
2013
- 2013-12-16 JP JP2013259499A patent/JP2014065732A/ja active Pending
-
2016
- 2016-10-27 HR HRP20161408TT patent/HRP20161408T1/hr unknown
- 2016-11-07 SM SM201600397T patent/SMT201600397B/it unknown
- 2016-11-16 CY CY20161101180T patent/CY1118536T1/el unknown
-
2020
- 2020-10-13 NL NL301067C patent/NL301067I2/nl unknown
- 2020-10-15 LT LTPA2020530C patent/LTPA2020530I1/lt unknown
- 2020-10-15 FR FR20C1050C patent/FR20C1050I2/fr active Active
- 2020-10-16 CY CY2020034C patent/CY2020034I2/el unknown
- 2020-10-19 FI FIC20200039C patent/FIC20200039I1/fi unknown
- 2020-10-21 NO NO2020035C patent/NO2020035I1/no unknown
- 2020-10-21 HU HUS2000042C patent/HUS2000042I1/hu unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20200039I1 (fi) | Kefiderokoli valinnaisesti farmaseuttisesti hyväksyttävän suolan tai solvaatin muodossa | |
| FIC20230039I1 (fi) | Sedatsuridiini tai tämän farmaseuttisesti hyväksyttävä suola | |
| NO2020018I1 (no) | Darolutamide, optionally in the form of a pharmaceutically acceptable salt or ester thereof | |
| NO2019042I1 (no) | Talazoparib, eventuelt i form av et farmasøytisk aksepterbart salt | |
| NO2020006I1 (no) | upadacitinib or a pharmaceutically acceptable salt thereof | |
| NO2020037I1 (no) | alpelisib eller et farmasøytisk akseptabelt salt derav | |
| FIC20210017I1 (fi) | Kabotegraviiri tai sen farmaseuttisesti hyväksyttävä suola tai solvaatti | |
| NO2022033I1 (no) | Rimegepant or a pharmaceutically acceptable salt thereof | |
| NO2019024I1 (no) | Brigatinib eller et farmasøytisk akseptabelt salt derav | |
| NO2022057I1 (no) | Capmatinib or a pharmaceutically acceptable salt thereof | |
| HUS000509I2 (hu) | Abemaciklib vagy egy gyógyászatilag elfogadható sója | |
| FIC20230017I1 (fi) | Mitapivaatti tai sen farmaseuttisesti hyväksyttävä suola, erityisesti mitapivaattisulfaatti | |
| FIC20230033I1 (fi) | Piflufolastaatti (18F) tai sen farmaseuttisesti hyväksyttävä suola | |
| NO2017059I1 (no) | ribosiklib eller et farmasøytisk akseptabelt salt derav | |
| NL301176I2 (nl) | Tepotinib en farmaceutisch aanvaardbare solvaten en zouten daarvan | |
| NO2019027I1 (no) | kobicistat eller et farmasøytisk akseptabelt salt derav | |
| FIC20200037I1 (fi) | Otsanimodi tai sen farmaseuttisesti hyväksyttävä suola, erityisesti otsanimodihydrokloridi | |
| NL301166I2 (nl) | Avacopan of een farmaceutisch aanvaardbaar zout daarvan | |
| NO2020039I1 (no) | Ozanimod eller et farmasøytisk akseptabelt salt derav, særlig ozanimodhydroklorid | |
| CY2018030I2 (el) | Φαρμακοτεχνικη μορφη 514 | |
| NO2023040I1 (no) | Atogepant or a pharmaceutically acceptable salt thereof | |
| NO2020038I1 (no) | Ozanimod, or a pharmaceutically acceptable salt thereof, including the hydrochloride salt | |
| NO2017024I1 (no) | Elosulfase alfa eller et farmasøytisk akseptabelt salt derav | |
| FIC20230001I1 (fi) | Lasmiditaani tai tämän farmaseuttisesti hyväksyttävä suola | |
| NL300998I1 (nl) | Lusutrombopag of farmaceutisch aanvaardbare zouten of solvaten daarvan |